Novel Compounds Targeting TLR/mTOR Signaling Pathways for Multiple Sclerosis Treatment
Research exploring toll-like receptor inhibition and mTOR pathway reversal to reduce neuroinflammation and neurodegeneration in Multiple Sclerosis, building on prior success in epilepsy and Alzheimer's models with novel ...